12-month liquidity sufficiency for operations and debt service
Company: Core Scientific
What the later record shows
Delivered on time · happened March 31, 2025
The company held $836.2M in cash at year-end 2024 and $697.9M at March 31, 2025, which is consistent with funding operations and debt service through the 12-month window. No passage reports a liquidity shortfall.
“Cash and cash equivalents $ 836,197 $ 50,409 $ 15,884”
2025-02-26 · Core Scientific 10-K filed 2025-02-27 View cached copy (2026-08-31)Live source ↗
“Cash and cash equivalents $ 697,942 $ 98,125 Restricted cash 783 16,151”
2025-05-06 · Core Scientific 10-Q filed 2025-05-07 View cached copy (2026-08-31)Live source ↗
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Management has concluded that as of March 31, 2024, the Company's capital, liquidity and cash flow from operations is sufficient to fund its operations and debt service obligations for at least 12 months
Source (primary)
Core Scientific 424B3 filed 2024-05-09 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “management has concluded that as of March 31, 2024, the Company's capital, liquidity and cash flow from operations is sufficient to fund its operations and debt service obligations for at least the next 12 months from the date these consolidated financial statements were issued”
How we checked this
Checked on October 11, 2026. The cited source supports every part of this claim.
The Liquidity and Financial Condition note in the Q1 2024 10-Q states this management conclusion directly. It covers both operations and debt service for at least the next 12 months.
Confirmed in the source:
- Core Scientific management concluded that, as of March 31, 2024, the Company's capital, liquidity and cash flow from operations were sufficient to fund its operations and debt service obligations.
- The sufficiency conclusion covers at least the next 12 months from the date the consolidated financial statements were issued.
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000162828024022276/prospectussupplement.htm) in full (212,137 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2024-05-09
Quote: “management has concluded that as of March 31, 2024, the Company's capital, liquidity and cash flow from operations is sufficient to fund its operations and debt service obligations for at least the next 12 months from the date these consolidated financial statements were issued”
confirms Core Scientific 10-K filed 2025-02-27
Quote: “Cash and cash equivalents $ 836,197 $ 50,409 $ 15,884”
confirms Core Scientific 10-Q filed 2025-05-07
Quote: “Cash and cash equivalents $ 697,942 $ 98,125 Restricted cash 783 16,151”